Literature DB >> 3512169

Cholinesterase phenotyping: clinical aspects and laboratory applications.

R T Evans.   

Abstract

The measurement of cholinesterase activity in human serum is an important investigation, especially in patients suspected of poisoning with organophosphate insecticides, or those experiencing prolonged paralysis following treatment with the short acting muscle relaxant succinylcholine. Appropriate clinical management of affected individuals can only be instituted if enzyme activity is measured using a method capable of clear interpretation and phenotypic ascription of cholinesterase, ascertained by use of selected enzyme inhibitors, is reliable. This review considers factors which lead to significant cholinesterase abnormalities and advises on the techniques most appropriate to their investigation. It is concluded that no one method is suitable both for measurement of activity and determination of genotype. The use of propionyl thiocholine is recommended for the first procedure and benzoyl choline for the latter. Those laboratories in which a request for the assessment of cholinesterase status is an unusual event should make greater use of assistance from colleagues whose experience with the problem is greater.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3512169     DOI: 10.3109/10408368609165794

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  4 in total

1.  Identification of the E1fE1k cholinesterase genotype.

Authors:  A M Burgess
Journal:  J Med Genet       Date:  1988-08       Impact factor: 6.318

2.  Pseudo-cholinesterase polymorphism in Mazandaran province (North of Iran).

Authors:  Ebrahim Zabihi; Meisam Shabanzadeh; Sina Arabsheibani; Ali Akbar Moghadamnia; Mahmoud Baradaran
Journal:  Caspian J Intern Med       Date:  2012

3.  Selected Gamma Aminobutyric Acid (GABA) Esters may Provide Analgesia for Some Central Pain Conditions.

Authors:  Joel S Goldberg
Journal:  Perspect Medicin Chem       Date:  2010-08-03

4.  Resorcinol-, catechol- and saligenin-based bronchodilating β2-agonists as inhibitors of human cholinesterase activity.

Authors:  Anita Bosak; Anamarija Knežević; Ivana Gazić Smilović; Goran Šinko; Zrinka Kovarik
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.